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Abstract The US healthcare system is currently facing
daunting demographic and economic challenges. Because
musculoskeletal disorders and disease represent a sub-
stantial and growing portion of this healthcare burden,
novel approaches will be needed to continue to provide
high-quality, affordable, and accessible orthopaedic care to
our population. The concept of ‘‘disruptive innovations,’’
which has been studied and popularized by Harvard
Business School Professor Clayton Christensen, may offer
a potential framework for developing strategies to improve
quality and control costs associated with musculoskeletal
care. The introduction of mobile ﬂuoroscopic imaging
systems, the development of the Surgical Implant Gener-
ation Network intramedullary nail for treatment of long
bone fractures in the developing world, the expanding role
and contributions of physician assistants and nurse practi-
tioners to the orthopaedic team, and the rise of ambulatory
surgery centers are all examples of disruptive innovations
in the ﬁeld of orthopaedics. Although numerous cultural
and regulatory barriers have limited the widespread adop-
tion of these ‘‘disruptive innovations,’’ we believe they
represent an opportunity for clinicians to regain leadership
in health care while at the same time improving quality and
access to care for patients with musculoskeletal disease.
Introduction
The cost of delivering health care in the United States has
become one of the most important public policy issues of
the 21st century. The percentage of the US gross domestic
product (GDP) that has been consumed by health care has
grown from 5% in 1960 to a staggering 16% in 2007 [3].
According to latest projections by the Congressional
Budget Ofﬁce, unless drastic measures are undertaken to
control healthcare spending in the United States, total
national spending on health care will claim more than 30%
of the GDP by 2035 and approximately 50% by 2082 [8].
Although the problem is clearly multifactorial, many health
policy analysts have pointed to the adoption of new and
advanced healthcare technologies as one of the primary
drivers of cost [11]. The United States leads the world in
biomedical research, and we have shown we can develop
the most sophisticated care to tackle the most complex
medical problems. However, our ability to deliver care
effectively and efﬁciently to all who need it is woefully
inadequate as evidenced by the high number of un- and
underinsured citizens and our low ranking in measures of
public health relative to other developed countries [22].
Thus, both the future health and viability of the US econ-
omy and its population are intimately related to the
thoughtful and responsible adoption of new healthcare
technologies.
Given past utilization rates and future demographic
trends, the ﬁeld of orthopaedic surgery can expect to be
particularly impacted by this impending economic crisis.
According to national healthcare statistics, musculoskeletal
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account for more than half of all chronic conditions in
people over the age of 50 [26]. During the period 2002 to
2004, over 83 million Americans reported one or more
spine conditions, and 42 million Americans reported
arthritis and joint pain [19, 26]. This resulted in an increase
in ambulatory physician visits for musculoskeletal care
from 426 million in 1996 to 1998 to 508 million in 2002 to
2004 as well as a 69% increase in total non-MD ambula-
tory care visits over that same time period [26]. The
economic impact of these trends is substantial. In 2004, the
sum of direct and indirect expenditures for the burden of
musculoskeletal ailments was $849 billion, or 7.7% of the
GDP [26].
Moreover, in the next 20 years, the estimated increase of
35 million North Americans over the age of 55 will further
amplify the burden of musculoskeletal disease [5]. Nearly
50% of inpatient procedure volume is driven by individuals
over the age of 65, and it is estimated that by the year 2030,
close to 20% of the US population will have entered this
age cohort [27]. Compounding the demographic trend of an
aging baby boomer population, this unique cohort in
American history has higher expectations of the healthcare
system than any generation before them.
Although the future of the American healthcare system
is wrought with both demographic and economic chal-
lenges, neither need prove insurmountable. In his research
on ‘‘Disruptive Innovations’’ in health care, Harvard
Business School Professor Clayton Christensen and his
colleagues provide valuable insight into one possible
strategy to address this challenging, seemingly intractable
problem [7]. This article presents the basic principles of
‘‘disruptive innovations,’’ documents their precedence in
and relation to the healthcare system, and provides speciﬁc
examples from the ﬁeld of orthopaedic surgery. In our
concluding remarks, we address the inherent cultural and
regulatory barriers to adoption of these ‘‘disruptive inno-
vations’’ and offer some possible strategies to overcome
these obstacles.
Disruptive Innovations
In his book, ‘‘The Innovator’s Dilemma,’’ Christensen
deﬁnes disruptive innovations as ‘‘cheaper, simpler, more
convenient products or services that start by meeting the
needs of less-demanding customers’’ [6]. According to
Christensen’s research, disruptive innovations arise in
every industry. Although the dominant players in a par-
ticular market sector focus on improving the functionality
of their products or services to meet the needs of the most
sophisticated customers at the high end of the market, they
often miss the simpler, more convenient, and less costly
alternatives initially designed to appeal to the least
demanding customers at the low end of the market. Over
time, the simpler (frequently technologically inferior)
products and services get better and are eventually able to
meet the needs of the vast majority of consumers.
Sustaining innovations are those products and services
marketed toward consumers at the higher end of the
market. To remain leaders in their ﬁeld, industries invest
in research and development to create a progressively
more sophisticated product, which is characterized by a
steadily increasing trajectory of technologic improvement
(Fig. 1, top solid line). There are numerous examples of
sustaining innovations in orthopaedics such as alternative
hip replacement bearing surfaces, computer-assisted sur-
gical navigation tools, total disk arthroplasty, locking
plates, and bone graft substitutes. Although these new
technologies represent important developments that may
advance the ﬁeld of orthopaedics, expand the indications
for orthopaedic procedures, and improve patient out-
comes, they do not necessarily address the needs of the
majority of our patients nor do they help address the
problems of limited accessibility and affordability of
musculoskeletal care.
Consumers’ ability to absorb or use the technologic
advances of any innovation is ﬁnite (Fig. 1, area between
the dashed lines). Furthermore, the pace of sustaining
innovation nearly always outstrips the ability of consumers
to absorb the improvements in functionality. This creates
the potential for the introduction of disruptive innovations
that start by meeting the needs of the least demanding
consumers at the low end of the market (Fig. 1, bottom
dashed line). The performance trajectory of these
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Fig. 1 The performance trajectory over time of disruptive versus
sustaining innovations is shown. The area between the dashed lines
outlines the rate of improvement consumers can absorb over time.
The pace of sustaining innovation nearly always outstrips the ability
of customers to absorb it, thereby creating the potential for the
introduction of disruptive innovations. The progress of these disrup-
tive innovations is shown by the bottom solid line. (Reprinted with
permission from Christensen CM, Bohmer R, Kenagy J. Will
disruptive innovations cure health care? Harv Bus Rev.
2000;78:102–112, 199.)
Volume 467, Number 10, October 2009 Impact of Disruptive Innovations in Orthopaedics 2513
123disruptive innovations has a distinct but similar vector of
technologic improvement compared with sustaining inno-
vations (Fig. 1, bottom solid line). Over time, the
functionality of these technologies improves, and eventu-
ally, they are capable of meeting the needs of the vast
majority of consumers.
Christensen goes on to argue that the ‘‘phenomenon of
overshooting the needs of the average consumer and cre-
ating the potential for disruption quite accurately describes
the current situation faced by the healthcare industry’’ [7].
Sustaining innovations such as emerging technologies,
specialist physicians, and academic teaching hospitals
constantly strive to improve their functionality to address
the needs of the sickest, most complex patients with the
most demanding healthcare problems. No one would argue
that these entities are contributing to the progress in the
ﬁeld of medicine. However, in a world of limited health-
care resources and a nation where the most medically
complex patients make up a minority of the population, it
could be argued that our focus should be redirected toward
identifying and developing disruptive innovations. This
could start by addressing the needs of less medically
complex patients but over time could be used to facilitate
higher-quality, more convenient, more accessible, and less
costly care to the majority of healthcare consumers in the
United States.
The ﬁeld of orthopaedics is constantly undergoing rapid
development through ongoing basic science and clinical
investigation. Currently, the focus of most biomedical
researchers and the pharmaceutical, medical device, and
biotechnology industries is disproportionately centered on
sustaining innovations, because of organizational structures
and ﬁnancial incentives. For these reasons, the impact of
disruptive innovations on the future of orthopaedics and the
health care of the nation can only be realized with a change
in perspective and a reallocation of healthcare dollars.
In the next sections, examples of disruptive innovations
in four areas of orthopaedic care delivery illustrate various
manners in which they may impact the healthcare system.
In ‘‘Diagnostics’’, we focus on the introduction and popu-
larization of the mini-ﬂuoroscan as a means of facilitating
and increasing access to real-time imaging. In ‘‘Surgical
Techniques and Technologies’’, the Surgical Implant
Generation Network (SIGN) intramedullary nail is ana-
lyzed as a ‘‘low-tech’’ treatment option to improve the level
and access of orthopaedic fracture care in the developing
world. The expanding role and contributions of physician
assistants (PAs) and nurse practitioners (NPs) to the
orthopaedic team is the topic of the discussion on disrup-
tive innovations in ‘‘Care Processes.’’ Finally, in
‘‘Healthcare Delivery Systems’’, we analyze the various
ways in which institutions have attempted to implement the
paradigm of ‘‘patient-centered care’’ by modifying existing
programs and care delivery models, focusing speciﬁcally
on the rise of ambulatory surgery centers.
Diagnostics: Point-of-service Radiology:
the Mini-ﬂuoroscan
Mini-ﬂuoroscans, or mini C-arms, are mobile ﬂuoroscopic
imaging systems designed for point-of-service, real-time
images that have the potential to increase access and
decrease costs in the delivery of high-quality orthopaedic
care. They are gaining popularity in operating rooms,
emergency departments, and physician ofﬁces because of
their mobility, simplicity of use, lower cost, and lower-dose
radiation compared with their full-size counterparts.
Clearly, they do not currently offer the same image quality
or functionality that full-scale ﬂuoroscopy units or digital
radiography equipment can provide, and they would not be
appropriate for use in many complex procedures such as
pedicle screw placement or open reduction internal ﬁxation
of a long-bone fracture. However, technologic advances
have enabled these devices to provide adequate image
quality for less complicated interventions such as evaluat-
ing the alignment of a distal radius fracture after closed
reduction, allowing dynamic evaluation of small joint sta-
bility, or assessing the adequacy of reduction and hardware
placement in the operative treatment of certain fractures.
As a disruptive innovation, mini-ﬂuoroscans offer the
ability to reduce the costs associated with using radiology
technicians and radiologists while at the same time
increasing the autonomy of the orthopaedic surgeon to
obtain and interpret his or her own radiographs. In addition,
the ability to obtain real-time images cuts down on the
cumulative time and money spent waiting for conventional
radiographs to be obtained, processed, and then either
printed or uploaded onto a picture archiving and commu-
nication system. As the technology reliably improves such
as image resolution and cordless foot pedals, it is expected
that the indications for use of the mini C-arm will increase.
Currently, there are two types of mini C-arm units
available in the United States: the Fluoroscan (Hologic,
Inc, Bedford, MA) and the Xitec XiScan (F&M Control,
SL, Vitoria, Spain). In a study comparing the mini-ﬂu-
oroscan with a conventional mobile C-arm on its ability to
maintain image quality while (1) delivering the lowest
possible radiation exposure to both patient and physician;
and (2) minimizing operator effort and inconvenience, the
authors of the study rated the mini C-arm as ‘‘acceptable’’
in both categories [10].
Ideally, increased use of mini C-arms could result in
improved patient outcomes and increased autonomy of the
orthopaedic surgeon while reducing the need for radiology
technicians to operate conventional ﬂuoroscopy units, thus
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The mini C-arm allows orthopaedic surgeons, emergency
department physicians, and nonphysician providers to
obtain ﬂuoroscopic images, view the images in real time on
a monitor, save and retrieve them later, or have a printout
immediately available during the closed management of
fractures. With the increased volume of patients presenting
to physician ofﬁces, urgent care clinics, and emergency
departments and the high use of plain radiography, the
ability to substitute the use of the mini C-arm for the use of
conventional ﬂuoroscopy and digital radiography could
lead to reliable cost savings and a decreased burden on the
healthcare workforce.
Fluoroscan, a division of Hologic, Inc, illustrates the
natural progression of disruptive innovations to a tech-
nology sector and speciﬁcally within a single company.
Within a year of expanding their product line by intro-
ducing the Premier mini C-arm to their already established
conventional C-arm market, the success of the Premier
resulted in the discontinuation of its larger, standard-sized
C-arm. Hologic executives attribute the success to the
user-friendly interface of the mini C-arm and the advent of
a proprietary beam alignment technology called Laser
Aiming Device (LAD) [23]. The LAD enables the user to
position the desired part of the anatomy in the center of
the imaging ﬁeld when the input surface of the image
intensiﬁer is obscured by drapes, arm boards, or other
objects present in the operating room. Currently, the
company is focusing on improving their product by
making the system even easier to use and streamlining
system housekeeping functions like image storage and
transfer. This example illustrates how a relatively simple
technology that was originally inferior in functionality
improved over time and was eventually able to meet the
needs of most mainstream consumers, thus displacing its
higher functionality predecessor (sustaining innovation)
for certain indications.
Surgical Techniques & Technology: SIGN (Surgical
Implant Generation Network) System to ‘Create
Equality of Fracture Care Throughout the World’
The SIGN system was developed in 1999 to address the
orthopaedic needs of the developing world and represents a
surgical technique and technology as a disruptive innova-
tion. Its founder, Dr Lewis Zirkle, explains the SIGN
intramedullary nail was founded to ‘‘create equality of
fracture care throughout the world’’ [25]. Rather than
incorporating the newest technologic advancements or
design modiﬁcations to address the needs of the higher end
of the fracture care market, the nail was speciﬁcally
designed to be ‘‘low tech,’’ easy to use, and inexpensive to
manufacture. Speciﬁcally, the SIGN system relies on hand
drills and reamers as well as a rigid slotted jig for place-
ment of interlocking screws. This response to the
recognized lack of access to ﬂuoroscopy and reliable power
instrumentation in many countries in the developing world
represents the way in which a disruptive innovation can
increase access to treatment. Currently, approximately
40,000 SIGN nail procedures have been performed in over
140 programs in 40 countries [25].
In addition to a surgical technique adapted for a
resource-poor healthcare system, the SIGN system itself
was developed to be inexpensive to manufacture, highly
versatile, and widely available. A set of 100 nails, complete
with the instrumentation, is sold for an initial cost of
$20,000. The nails themselves can be used for the humerus,
tibia, and femur and inserted either in antegrade or retro-
grade fashion. Furthermore, the philosophy behind the
SIGN system is to provide not only equitable, but sus-
tainable fracture care. As such, a replacement nail and the
interlocking screws are sent free of charge for each one that
is used as long as the treating surgeon systematically
reports the details of the clinical case, implants used, and
postoperative radiographs on the SIGN web site’s surgical
database.
There are two published, peer-reviewed journal articles
on clinical and radiographic outcomes after treatment with
the SIGN nail system. One manuscript reviews the short- to
midterm results of the SIGN nail for treatment of open tibia
fractures in Kathmandu, Nepal, whereas the other reports
on a consecutive series of patients who were treated with
SIGN nails for extremity fractures in Nigeria [12, 24]. Both
studies report a high degree of clinical success with a low
incidence of complications. In Nepal, Shah et al. were able
to demonstrate that 86% of (31 of 36) open tibia fractures
healed within 6 months with only an 8% infection rate
[24]. Similarly, Ikem and colleagues reported a mean time
to union of 3 months, no missed interlocking screws, and a
low complication rate. In their series of 40 patients, there
were two cases of superﬁcial infection, one interlocking
screw failure from osteoporotic bone, and two delayed
unions [12].
Like all disruptive innovations, the SIGN intramedullary
nail system is not a static entity, but rather is evolving into
other areas of fracture care. Recently, Dr Zirkle developed
a SIGN system for internal ﬁxation of hip fractures that
does not rely on power instruments or ﬂuoroscopy, which
is called the SIGN hip construct. The ﬁrst clinical case in
which this system was used occurred at Wazir Akbar Khan
Hospital in Kabul, Afghanistan, in a patient who sustained
an intertrochanteric hip fracture. The translation of the
SIGN surgical technique and instrumentation from long
bone fractures to hip fractures clearly demonstrates the
manner in which the performance trajectory of a disruptive
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needs of more demanding consumers (Fig. 1, solid bottom
line).
Process of Care: Physician Assistants and Nurse
Practitioners—Colleagues, Not Competitors
The increased role of physician assistants (PAs) and nurse
practitioners (NPs) in orthopaedic surgical practice is an
example of healthcare providers as a disruptive innovation,
because they are able to help facilitate increased access and
lower costs associated with delivering high-quality ortho-
paedic care. Although the establishment and development
of the ﬁrst formal PA and NP educational programs and
professional organizations occurred in the mid-1960s, it
was not until the 1980s and 1990s that there was a rapid
expansion of PA and NP training programs. At that time,
healthcare legislation was revised to reduce barriers to use
PA and NP services in a variety of healthcare settings.
HMOs recognized the important roles of PAs and NPs in
controlling costs, and restrictions on resident duty hours
spurred employment and postgraduate learning opportuni-
ties in hospital inpatient settings [18]. Twenty-three percent
(11,500) of the estimated 50,000 clinically practicing PAs
work in surgical specialties or subspecialties, and there are
currently 5000 PAs employed in the ﬁeld of orthopaedics
in the United States [1].
Christensen et al. have noted that many of the most
potent disruptive innovations in health care achieved suc-
cess by ‘‘enabling a larger population of less-skilled people
to do in a more convenient, less costly setting things that
historically could be performed only by expensive spe-
cialists in centralized, inconvenient locations’’ [7]. For PAs
and NPs in orthopaedics, common responsibilities include
taking evening and weekend calls as well as emergency
department coverage, performing admission history and
physical examinations, ﬁrst-assisting in the operating room,
providing patients with preoperative information and
postoperative instructions, and performing dressing and
cast changes [13]. Many of these tasks and roles that used
to be performed by surgeons are clearly within the capa-
bilities of certiﬁed PAs and NPs and for a fraction of the
cost. Moreover, according to the Medical Group Manage-
ment Association (MGMA), PAs and NPs often generate
revenue that more than covers their compensation. MGMA
collects data annually comparing PA compensation with
gross charges. According to 2002 data, for PAs in surgical
practices, the employer pays 32 cents for every dollar of
charges generated [17]. This cost savings is experienced
both at the practice and national level. As of January 1,
1998, Medicare pays PAs 85% of the physician fee sche-
dule, which also holds true for ﬁrst-assisting during
surgery. For a surgical procedure, this translates to
approximately 14% of the primary surgeon’s fees (ie, 85%
of physician ﬁrst assistant fees, which is 16% of the sur-
geon’s fees) [1].
When an appropriate level of responsibility is bestowed
on the PA or NP, quality of care is not sacriﬁced. In fact,
studies of patient satisfaction have shown a high level of
satisfaction with care provided by PAs and NPs. In 1994,
the Federal Advisory Group on Physician Assistants and
the Workforce concluded that published research since the
profession began consistently found a high level of patient
acceptance. Furthermore, a comprehensive 1995 to 1996
Kaiser study evaluating patient satisfaction with PAs, NPs,
certiﬁed nurse midwives, and physicians in a managed care
setting concluded that ‘‘patient satisfaction with interper-
sonal care appears to depend on communication style and
not on type of provider’’ [21]. With the anticipated changes
in demographics in the coming decades, it can be expected
that PAs and NPs will play an increasingly important role
in the orthopaedic team by assuming a larger share of the
nonoperative aspects of the orthopaedic patients’ care, thus
allowing orthopaedic surgeons to focus on the surgical
management of musculoskeletal disease.
Healthcare Delivery Systems: The Rise of Ambulatory
Surgery Centers
Although technological advancements and the expanding
role of ancillary staff may contribute to improved access
and care, the greatest opportunities to improve the health-
care system as a whole and the care provided to the
population is to focus on and modify the healthcare
delivery systems currently in place. Recently, there has
been increased awareness that the current hospital system
in the United States fails the individual patient in many
regards as a result of the fragmented provision of care by
multiple providers in a myriad of settings. In response to
this, there has been an emphasis on patient-centered or
patient-focused care as a low-technology solution to the
existing problems. Single-specialty hospitals and ambula-
tory surgery centers (ASCs) have consistently enjoyed high
patient volumes and high satisfaction rates, in part because
of their ability to deliver focused, efﬁcient, high-quality
patient-centered care. In a recently published study, Cram
and colleagues reported that even after adjusting for
numerous important facility and patient characteristics
such as bed size, teaching status, and patient comorbidities,
specialty orthopaedic hospitals delivered higher-quality
care to orthopaedic patients than their general hospital
counterparts [9]. In response to this, general hospitals have
had to modify their service lines and implement operational
efﬁciencies in an attempt to compete for orthopaedic
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As noted by Christensen et al., the basis for competition for
many less complicated procedures such as elective ortho-
paedic surgery has changed to reward reliability,
accessibility, convenience, and low cost rather than higher
functionality [7].
Ambulatory surgery centers satisfy the criteria for a
disruptive innovation in the ﬁeld of care delivery in that
they are a cheaper, simpler, more convenient alternative to
hospital operating rooms, and they were initially designed
to appeal to the low end of the market. An ASC is a facility
that by deﬁnition provides surgical treatment that does not
require hospitalization. These facilities were initially tai-
lored toward healthier patients requiring minor elective
procedures. Orthopaedic subspecialties amenable to
ambulatory surgery include arthroscopy, sports-related
injuries, hand, some spine as well as foot/ankle procedures,
and the list is expanding.
Many of the initial ASCs struggled after their debut in
1972 as a result of inadequate reimbursement and the need
to establish themselves in the eyes of investors as a high-
quality, proﬁtable investment. After 1982 and the approval
of Medicare reimbursement for ASCs, there has been
substantial growth in the number of ASCs in the United
States. Today there are more than 4000 ASCs throughout
the United States compared with 275 in 1980 and 1450 in
1990 [2, 14]. From 1996 to 2003, the number of ASCs
increased by 50%, from 2425 to 3646, whereas the number
of hospital-based outpatient surgery centers dropped by
16% [20]. One of the primary reasons for the success of
ASCs when compared with hospital-based outpatient sur-
gery centers is their proﬁtability. The Pennsylvania Health
Cost Containment Council reports that free-standing ASCs
have an average net margin of 12%, whereas hospital
outpatient surgery centers are on average barely proﬁtable
at 2% [20]. These differences in proﬁtability have led to
payment reforms that have limited payment for ASCs to
65% of the payment for hospital-based outpatient surgery
centers for the same procedures [16]. These types of mis-
guided payment reforms incentivize less efﬁcient care and
threaten the future viability of ASCs to deliver high-qual-
ity, cost-efﬁcient care.
The literature supports the fact that increased volume
and proﬁts have not come at the expense of quality of care.
In fact, the American Association for Accreditation of
Ambulatory Surgery Facilities, in its ongoing effort to
improve patient care, has developed an Internet-based
quality improvement and peer review program to analyze
outcomes for the surgery centers it accredits. Each surgeon
must report all unanticipated sequelae, and at least six
random cases are reviewed by an accepted peer review
group biannually. In a study conducted over 2 years (2001
to 2002), one unanticipated sequelae occurred in every 299
procedures (incidence of 0.33%), and a death occurred in
one in 58,810 procedures (0.0017%), which was compa-
rable whether the procedure was performed in an
accredited ambulatory surgery facility or a hospital-based
surgical facility [15]. Thus, it appears that ASCs, rather
than being static entities, are constantly innovating,
streamlining, and incorporating technologic advances in
surgical devices, techniques, and anesthesia protocols to
expand the conditions for which same-day surgery is safe
and appropriate.
Reasons for Nonadoption: Barriers to Progress
Disruptive innovations in health care, in theory, offer lower
cost, more efﬁcient and convenient alternatives while
maintaining, if not improving, the quality of care provided
to patients. Therefore, it might seem unusual that there
would be any resistance to their adoption. Yet as Chris-
tensen aptly notes, ‘‘healthcare may be the most
entrenched, change-averse industry in the United States’’
[5]. From physicians to hospitals, health plans to implant
manufacturers and regulators, it appears many stakeholders
in the US healthcare system support the status quo to
maintain their positions and proﬁts. Although no one would
blame the fact that most healthcare stakeholders feel a keen
sense of defensiveness to protect their piece of an ever
diminishing pie, without thoughtful, voluntary sacriﬁce, we
risk losing control of how our piece is divided. It is at these
crossroads speciﬁcally where providers can regain some
control of the practice of medicine. The rise of managed
care, changes in reimbursement rates from third-party
payers, and the diffusion of new technologies to the market
have intensiﬁed ‘‘turf wars’’ between the different profes-
sional guilds of medical practitioners. Disruptive
innovations, some would argue, are only stoking the
ﬂames, because they allow procedures to be performed
more efﬁciently in a more convenient location by providers
who had previously been unable to provide such a service.
In orthopaedic surgery, examples of ‘‘turf wars’’ include
the ongoing battle with radiologists over the use of in-
ofﬁce diagnostic imaging and conﬂicts with podiatrists and
physical therapists over the scope of their practice. These
disputes are provider-centric conﬂicts that consume valu-
able resources and energy that could be redirected to
enhance the value of care we provide by increasing quality
and reducing costs.
Hospitals, by virtue of their size, associated overhead,
and their large investments in the latest sustaining tech-
nologies, are similarly wary of disruptive innovations,
because they may threaten their long-term ﬁnancial via-
bility. The rise in ASCs and single-specialty hospitals have
shown investors and physicians alike that high-quality care
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when facilities are patient-oriented, care delivery and
operations are streamlined, and physicians and personnel
are well integrated. Clearly, general hospitals are at a
distinct disadvantage when it comes to ‘‘competing’’ for
proﬁts with standalone ASCs and single-specialty hospi-
tals, because the burden of the uninsured and underinsured
falls squarely on the shoulders of the former and the scope
of practice differs greatly between the various healthcare
delivery systems. However, comparisons can and should be
drawn between the greater operating efﬁciencies of the
ambulatory surgery centers as compared with hospital-
based outpatient surgery centers. The margin differentials
that exist between these two delivery systems cannot be
explained simply by the patient population cared for or
services provided. Although it may be true that ASC’s are
guilty of ‘‘cherry picking’’ patients, an analysis of the
systems in place in these facilities may provide valuable
lessons to improve the efﬁciencies of the hospital-based
outpatient surgery centers. Unfortunately, it appears many
hospitals are ill-equipped to compete in today’s ﬂexible,
highly competitive healthcare delivery market.
Commercial health plans and other third-party payers,
with their strong focus on proﬁt margins, would seem to be
an ally of disruptive innovations in that these technologies
hold the promise of providing cost savings without sacri-
ﬁcing quality of care. However, commercial payers only
reimburse for procedures that have been clinically vali-
dated, and many disruptive innovations, by virtue of being
recent entrants to the market, do not yet have peer-
reviewed research to support their efﬁcacy compared with
so-called ‘‘gold standard’’ treatment interventions. By
labeling many new potentially disruptive procedures as
‘‘investigational,’’ private insurers stiﬂe growth and inno-
vation that could lead to higher-quality, lower-cost care in
the long run.
The rise in direct-to-consumer advertising of hip and
knee replacement implants, primarily by implant manu-
facturers, but also by hospitals and surgeons, to gain a
more competitive position in the lucrative and expanding
arthroplasty market also poses a formidable institutional
barrier to the adoption of disruptive innovations. It is the
sustaining innovations that currently fuel the research and
development of the orthopaedic device manufacturers such
as alternative bearings for use in THA, computer-assisted
surgical navigation tools, and new suture ﬁxation devices.
Although these devices have the potential to improve
patient outcomes, they are consistently introduced into the
market at a substantial cost premium and before validation
of their clinical beneﬁt and cost-effectiveness through
well-designed, prospective clinical studies. Patients, as
consumers, are shielded from the costs of orthopaedic
implants and are often presented with misleading
information about the beneﬁts of particular products,
which in turn may lead to inappropriate demands for
newer, more costly, unproven technologies, strain the
physician-patient relationship, and potentially contribute
to the rising cost of health care [4].
Regulators, as opposed to physicians, care delivery
systems, and third-party payers, have no ﬁnancial incentive
to resist the diffusion of disruptive innovations. Although
originally established to protect both the consumer and
society from unforeseeable risk as well as enforce the
standards established by physicians, regulatory bodies
often indirectly curb the diffusion of disruptive innovations
by protecting and enforcing the status quo, which happens
to be on the side of sustaining innovations. One of the main
obstacles to diffusion of disruptive innovations stems from
a dearth of published research demonstrating safety and
efﬁcacy. The lengthy and cumbersome FDA approval
process for investigational devices and the bureaucratically
complex HIPAA regulations are two key examples of how
regulators indirectly impede the diffusion of disruptive
innovations. Additionally, the enforcement of stringent
intellectual property laws has the unintended consequence
of limiting the introduction of generic drugs and device
alternatives.
Discussion
The US healthcare system is clearly in crisis, and current
strategies have proven inadequate. Many healthcare insti-
tutions and healthcare technologies have overshot the
needs of most patients with nonlife-threatening conditions
who require elective surgical treatment such as many
orthopaedicpatients.AsChristensenetal.havenotedintheir
work, the market for simple, elective surgical procedures no
longer rewards higher functionality, but rather rewards
convenience, accessibility, low cost, and reliability [7].
In this article, we have applied the concept of disruptive
innovations popularized by Christensen to the ﬁeld of
orthopaedics to illustrate examples in which simpler,
cheaper alternatives have improved access of care,
increased patient satisfaction, and empowered clinicians to
provide higher-quality, more convenient and efﬁcient care
to their patients. Although we chose to focus on the speciﬁc
examples of disruptive innovations described, there are
many other potential examples related to musculoskeletal
care delivery, including calcium phosphate cement for the
treatment of distal radius fractures in the elderly, muscu-
loskeletal ultrasound, and ‘‘medical tourism.’’
One of the deﬁning characteristics of a disruptive
innovation is a performance trajectory that allows it to
eventually meet the demands of more sophisticated con-
sumers. Each of our examples has the potential to
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123continually evolve, improve, and thereby become ‘‘more
disruptive’’ over time. Speciﬁcally, the technology under-
lying the mini-ﬂuoroscans may improve to the point that
the image quality achieved is comparable to that of con-
ventional C-arms. Furthermore, although a number of the
larger C-arms now are able to create ﬂuoroscopic com-
puted tomography reformats for three-dimensional detail,
one could imagine that the mini C-arms may incorporate
this feature in the years to come. This would allow for an
expansion of current indications such as evaluation of
complex, intraarticular fractures by these smaller imaging
machines. Additionally, less expensive radiographic print-
ers may be developed to allow for point-of-service printing
of formal radiographs, thereby obviating any dependence
on the radiology department.
In regard to increasing the role of PAs and NPs, these
so-called ‘‘midlevel’’ providers have become an integral
part of most orthopaedic practices, functioning as primary
care musculoskeletal providers and thus allowing ortho-
paedic surgeons to focus on the surgical management of
musculoskeletal disease.
Similarly, ASCs will continue to grow their market
share as surgeons and anesthesiologists collaborate to
develop perioperative protocols that allow for more com-
plex procedures to be performed as ‘‘same day surgeries’’
without compromising safety (eg, improving preoperative
education, including the proper use of assistive devices,
providing appropriate preoperative education to patients
and their families, and discharging patients home with
indwelling pain catheters).
The sustaining orthopaedic innovations that are repeat-
edly introduced into the marketplace will continue to
beneﬁt our patients and advance the ﬁeld of orthopaedics.
To date, health care in general and the ﬁeld of orthopaedic
surgery in particular has focused a disproportionate share
of resources and effort on the problems of a medical
minority. To improve the overall health of the nation,
efforts and resources should be redirected toward tech-
nologies that improve access and tackle issues of
affordability to address the needs of the majority. Although
it would be naı ¨ve to believe all of the ills of the healthcare
system could be reversed simply by the development and
diffusion of disruptive innovations, not actively attempting
to identify and cultivate them will lead us further down our
current path toward unsustainable healthcare inﬂation and
an ever increasing gap between the health care we are
capable of delivering based on technologic innovation and
the health care we are able to deliver based on limited
resources. Moreover, the concept of disruptive innovations
offers the opportunity for clinicians to regain leadership in
health care by working together with other healthcare
leaders to deliver higher-quality, more convenient and
accessible cost-effective care to our patients.
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